WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

A STUDY ON PROTON PUMP INHIBITORS IN GENERAL MEDICINE UNIT OF TERTIARY CARE TEACHING HOSPITAL

Nirajan Kunwar*, M. Kumaraswamy, Surendra Shrestha, Saroj Paudel, Bipin Kafle, Thakur Pokharel, and Jamuna TR.

ABSTRACT

Background: The important factor for a widespread and inadequate use of PPIs seems to be the beginning of these medications during a patient’s hospitalization and its recommendation for continuation in primary care without appropriate reason. Administration of unnecessary medication could cause adverse effects and pharmacological interactions and lead to polypharmacy. Objective: To study the prescribing pattern of proton pump inhibitors. Methodology: A prospective and observational study was conducted in inpatients medicine department at Adichunchanagiri Hospital and Research Center for a period of 9 months. Results: A total of 130 sample population were studied, 63.85% were male and 36.15% were female. The results showed that the age between 60-80 years were more which constituted 43.84%. An appropriate use of PPIs was found to be 76.93% where as its inappropriate use was 23.07%. The PPIs were prescribing in NSAIDS used conditions was found to be (73.85%), followed by others disease conditions (23.07%) followed by GERD (2.31%) and PUD (0.77%). Conclusion: In this present study, the PPI was indicated more in NSAIDS used patients i.e 73.85% and the maximum days for continuation of PPIs therapy was one week which was found to be 73.25% but apparent reason for continuation of PPIs therapy was unclear. In total number of study population inappropriate use of PPIs was 23.07% hence PPI should be used only when there is documented evidence of a GI disorder that cannot be treated with an H2-receptor antagonist and where a PPI use is clinically justified.

Keywords: Proton Pump Inhibitors, Dyspepsia, Appropriateness, Peptic Ulcer Diseases, Non Steroidal Anti Inflammatory Drugs.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More